Global Firms See Risks in Russia

Related Link: 

U.S. and European companies are girding for the possible impact of tougher international sanctions against Moscow, with auto makers and energy giants moving to limit the Russia risks to their businesses.

Yelp Reports First Profit Since IPO

Related Link: 

Yelp reports its first profit as a public company, but concerns linger about the number of businesses added by the business-review website.

Buyout Shops Look to Rivals for Deals

Related Link: 

Private-equity firms are increasingly buying companies from each other, a shift driven in part by the relative simplicity of completing such an acquisition.

Kraft Foods Group Profit Tumbles

Related Link: 

Kraft Foods Group Inc. said second-quarter profit fell more than 40%, as a slight increase in revenue couldn't offset a substantial extraordinary gain in the same quarter a year ago.

GM to Start Taking Crash Claims

Related Link: 

General Motors on Friday starts taking applications from victims of accidents involving defective ignition switches in its small cars, promising the first payouts from the about $400 million fund by November.

Whole Foods Again Lowers Sales View

Related Link: 

Whole Foods said third-quarter earnings rose 6%, but the specialty supermarket again lowered its sales projections for the fiscal year.

AMC Entertainment's Profit Plunges

Related Link: 

AMC Entertainment Holdings Inc.'s second-quarter profit fell by nearly half as attendance at the company's movie theaters dropped.

IAC/InterActive Swings to Loss as Revenue Falls

Related Link: 

IAC/InterActiveCorp. swung to a second-quarter loss as revenue declined and the company took a write-down for its investment in online video service Aereo.

Loopholes Blunt Impact of U.S., EU Sanctions

Related Link: 

The immediate impact of sanctions imposed against Russian banks is likely to be muted, as the U.S. omitted Russia's biggest bank and Europe carved out a loophole for EU subsidiaries.

Researchers Fret as Social Media Lift Drug-Trial Veil

Related Link: 

Drug makers and researchers are increasingly concerned that online chatter could unravel the carefully built construct of the "blind" clinical trial.

Syndicate content